Literature DB >> 17599973

Differential expression of nephrin according to glomerular size in early diabetic kidney disease.

Jin-Ju Kim1, Jin Ji Li, Dong-Sub Jung, Seung-Jae Kwak, Dong-Ryeol Ryu, Tae-Hyun Yoo, Seung Hyeok Han, Hoon Young Choi, Hyung Jong Kim, Dae Suk Han, Shin-Wook Kang.   

Abstract

Diabetic nephropathy (DN) is clinically characterized by proteinuria. Many studies tried to demonstrate a relationship between proteinuria and changes in nephrin in various forms of glomerular diseases including DN, but the results are not consistent. Glomerular hypertrophy occurs in DN, yet hypertrophy does not develop in all glomeruli concurrently. For investigation of the differences in nephrin expression according to glomerular size, glomeruli were isolated from 10 control and 10 streptozotocin-induced diabetic rats at 6 wk after the induction of diabetes by a sieving technique using sieves with pore sizes of 250, 150, 125, and 75 microm. Glomeruli then were classified into large glomeruli (LG; on the 125-microm sieve) and small glomeruli (SG; on the 75-microm sieve) groups. Glomerular volumes were determined using an image analyzer, and mRNA and protein expression was determined by real-time PCR and Western blot, respectively. The mean volumes of diabetic LG (1.51 +/- 0.06 x 10(6) microm(3)) and control LG (1.37 +/- 0.05 x 10(6) microm(3)) were significantly higher than those of diabetic SG (0.94 +/- 0.03 x 10(6) microm(3)) and control SG (0.87 +/- 0.03 x 10(6) microm(3); P < 0.01). Nephrin mRNA expression was significantly reduced in the diabetic LG group compared with the diabetic SG and control glomeruli groups (P < 0.05). In contrast, nephrin mRNA expression was significantly higher in the diabetic SG group compared with the diabetic LG and control glomeruli groups (P < 0.05). Even after correction for 18s rRNA and Wilms' tumor-1 mRNA expression, the differences in nephrin mRNA expression remained significant. The expression of nephrin protein showed a similar pattern to the mRNA expression. In conclusion, these data suggest that the nephrin gene is differentially expressed according to glomerular size. Furthermore, more hypertrophied glomeruli with lesser nephrin expression may be responsible for albuminuria in the early stage of DN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599973     DOI: 10.1681/ASN.2006101145

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  23 in total

1.  The human nephrin Y1139RSL motif is essential for podocyte foot process organization and slit diaphragm formation during glomerular development.

Authors:  Eugenel B Espiritu; Huajun Jiang; Sophie Moreau-Marquis; Mara Sullivan; Kunimasa Yan; Donna Beer Stolz; Matthew G Sampson; Neil A Hukriede; Agnieszka Swiatecka-Urban
Journal:  J Biol Chem       Date:  2019-05-31       Impact factor: 5.157

2.  Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.

Authors:  Benoit Denhez; Farah Lizotte; Marie-Odile Guimond; Nina Jones; Tomoko Takano; Pedro Geraldes
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

3.  Effects of insulin and high glucose on mobilization of slo1 BKCa channels in podocytes.

Authors:  Eun Young Kim; Stuart E Dryer
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

4.  Early B Cell Factor 1 (EBF1) Regulates Glomerular Development by Controlling Mesangial Maturation and Consequently COX-2 Expression.

Authors:  Tracy Nelson; Heino Velazquez; Nancy Troiano; Jackie A Fretz
Journal:  J Am Soc Nephrol       Date:  2019-08-12       Impact factor: 10.121

5.  Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade.

Authors:  Genei Ihara; Hideyasu Kiyomoto; Hiroyuki Kobori; Yukiko Nagai; Naro Ohashi; Hirofumi Hitomi; Daisuke Nakano; Nicolas Pelisch; Taiga Hara; Takefumi Mori; Sadayoshi Ito; Masakazu Kohno; Akira Nishiyama
Journal:  J Hypertens       Date:  2010-11       Impact factor: 4.844

6.  The effects of sildenafil citrate on urinary podocin and nephrin mRNA expression in an L-NAME model of pre-eclampsia.

Authors:  Sooraj Baijnath; Saravanakumar Murugesan; Irene Mackraj; Prem Gathiram; Jagidesa Moodley
Journal:  Mol Cell Biochem       Date:  2016-12-19       Impact factor: 3.396

7.  Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

Authors:  Akira Nishiyama; Toshitaka Nakagawa; Hiroyuki Kobori; Yukiko Nagai; Noriyuki Okada; Yoshio Konishi; Takashi Morikawa; Michiaki Okumura; Isseiki Meda; Hideyasu Kiyomoto; Naohisa Hosomi; Takefumi Mori; Sadayoshi Ito; Masahito Imanishi
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

8.  Pathological influence of obesity on renal structural changes in chronic kidney disease.

Authors:  Shigeko Kato; Arifa Nazneen; Yumiko Nakashima; Mohammed S Razzaque; Tomoya Nishino; Akira Furusu; Noriaki Yorioka; Takashi Taguchi
Journal:  Clin Exp Nephrol       Date:  2009-04-29       Impact factor: 2.801

9.  Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors.

Authors:  Cecil Stanley Thompson
Journal:  World J Diabetes       Date:  2013-08-15

10.  Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.

Authors:  Hong-Zhao Xu; Wan-Ning Wang; Yuan-Yuan Zhang; Yan-Li Cheng; Zhong-Gao Xu
Journal:  J Nephrol       Date:  2016-03-28       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.